中华消化外科杂志
中華消化外科雜誌
중화소화외과잡지
CHINESE JOURNAL OF DIGESTIVE SURGERY
2014年
7期
520-524
,共5页
陈钰%任建安%秦晓东%周波%顾国胜%洪之武%阿基业%黎介寿
陳鈺%任建安%秦曉東%週波%顧國勝%洪之武%阿基業%黎介壽
진옥%임건안%진효동%주파%고국성%홍지무%아기업%려개수
全身炎症反应综合征%稳定性同位素%白蛋白%连续性静脉-静脉血液滤过
全身炎癥反應綜閤徵%穩定性同位素%白蛋白%連續性靜脈-靜脈血液濾過
전신염증반응종합정%은정성동위소%백단백%련속성정맥-정맥혈액려과
Systemic inflammatory response syndrome%Stable isotope%Albumin%Continuous veno-venous hemofiltration
目的 探讨连续性静脉-静脉血液滤过(CVVH)对全身炎症反应综合征(SIRS)患者Alb代谢率的影响.方法 回顾性分析2010年12月至2011年12月南京军区南京总医院收治的28例SIRS患者的临床资料.其中8例患者仅常规抗感染、对症治疗(对照组);10例患者行血液滤过治疗,血液滤过置换量为2 000 mL/h(低容量组);10例患者行血液滤过治疗,血液滤过置换量为4 000 mL/h(高容量组).采用稳定性同位素示踪技术,向患者同时静脉输注两种稳定性同位素标记的苯丙氨酸:[1-13C]苯丙氨酸和d5-苯丙氨酸.采用气相色谱质谱联用仪的选择离子检测模式检测质荷比为192、194、197、218和219片段的峰面积.采用数学模型计算Alb合成率(FSR)和分解率(FBR).多组比较采用单因素方差分析,组间比较采用LSD或Dunnett's T3检验.结果 对照组、低容量组和高容量组患者治疗前Alb FSR分别为5.8%±0.9%、5.7%±1.1%、5.7%±1.0%,3组比较,差异无统计学意义(F=0.04,P>0.05);治疗后Alb FSR分别为5.9%±0.8%、7.3%±0.9%、7.8%±1.1%,3组比较,差异有统计学意义(F=9.15,P<0.05).治疗后低容量组和高容量组患者Alb FSR均显著高于对照组患者(=3.40,3.96,P<0.05);低容量组和高容量组患者Alb FSR比较,差异无统计学意义(t=1.02,P>0.05).对照组、低容量组和高容量组患者治疗前Alb FBR分别为7.0%±1.2%、6.5%±0.9%、7.2%±1.2%,3组比较,差异无统计学意义(F =0.88,P>0.05);治疗后3组患者Alb FBR分别为6.9%±1.1%、6.2%±0.9%、7.4%±1.0%,3组比较,差异无统计学意义(F=2.82,P>0.05).结论 CVVH可调节SIRS患者蛋白代谢,能够提高Alb FSR,但不能降低Alb FBR.
目的 探討連續性靜脈-靜脈血液濾過(CVVH)對全身炎癥反應綜閤徵(SIRS)患者Alb代謝率的影響.方法 迴顧性分析2010年12月至2011年12月南京軍區南京總醫院收治的28例SIRS患者的臨床資料.其中8例患者僅常規抗感染、對癥治療(對照組);10例患者行血液濾過治療,血液濾過置換量為2 000 mL/h(低容量組);10例患者行血液濾過治療,血液濾過置換量為4 000 mL/h(高容量組).採用穩定性同位素示蹤技術,嚮患者同時靜脈輸註兩種穩定性同位素標記的苯丙氨痠:[1-13C]苯丙氨痠和d5-苯丙氨痠.採用氣相色譜質譜聯用儀的選擇離子檢測模式檢測質荷比為192、194、197、218和219片段的峰麵積.採用數學模型計算Alb閤成率(FSR)和分解率(FBR).多組比較採用單因素方差分析,組間比較採用LSD或Dunnett's T3檢驗.結果 對照組、低容量組和高容量組患者治療前Alb FSR分彆為5.8%±0.9%、5.7%±1.1%、5.7%±1.0%,3組比較,差異無統計學意義(F=0.04,P>0.05);治療後Alb FSR分彆為5.9%±0.8%、7.3%±0.9%、7.8%±1.1%,3組比較,差異有統計學意義(F=9.15,P<0.05).治療後低容量組和高容量組患者Alb FSR均顯著高于對照組患者(=3.40,3.96,P<0.05);低容量組和高容量組患者Alb FSR比較,差異無統計學意義(t=1.02,P>0.05).對照組、低容量組和高容量組患者治療前Alb FBR分彆為7.0%±1.2%、6.5%±0.9%、7.2%±1.2%,3組比較,差異無統計學意義(F =0.88,P>0.05);治療後3組患者Alb FBR分彆為6.9%±1.1%、6.2%±0.9%、7.4%±1.0%,3組比較,差異無統計學意義(F=2.82,P>0.05).結論 CVVH可調節SIRS患者蛋白代謝,能夠提高Alb FSR,但不能降低Alb FBR.
목적 탐토련속성정맥-정맥혈액려과(CVVH)대전신염증반응종합정(SIRS)환자Alb대사솔적영향.방법 회고성분석2010년12월지2011년12월남경군구남경총의원수치적28례SIRS환자적림상자료.기중8례환자부상규항감염、대증치료(대조조);10례환자행혈액려과치료,혈액려과치환량위2 000 mL/h(저용량조);10례환자행혈액려과치료,혈액려과치환량위4 000 mL/h(고용량조).채용은정성동위소시종기술,향환자동시정맥수주량충은정성동위소표기적분병안산:[1-13C]분병안산화d5-분병안산.채용기상색보질보련용의적선택리자검측모식검측질하비위192、194、197、218화219편단적봉면적.채용수학모형계산Alb합성솔(FSR)화분해솔(FBR).다조비교채용단인소방차분석,조간비교채용LSD혹Dunnett's T3검험.결과 대조조、저용량조화고용량조환자치료전Alb FSR분별위5.8%±0.9%、5.7%±1.1%、5.7%±1.0%,3조비교,차이무통계학의의(F=0.04,P>0.05);치료후Alb FSR분별위5.9%±0.8%、7.3%±0.9%、7.8%±1.1%,3조비교,차이유통계학의의(F=9.15,P<0.05).치료후저용량조화고용량조환자Alb FSR균현저고우대조조환자(=3.40,3.96,P<0.05);저용량조화고용량조환자Alb FSR비교,차이무통계학의의(t=1.02,P>0.05).대조조、저용량조화고용량조환자치료전Alb FBR분별위7.0%±1.2%、6.5%±0.9%、7.2%±1.2%,3조비교,차이무통계학의의(F =0.88,P>0.05);치료후3조환자Alb FBR분별위6.9%±1.1%、6.2%±0.9%、7.4%±1.0%,3조비교,차이무통계학의의(F=2.82,P>0.05).결론 CVVH가조절SIRS환자단백대사,능구제고Alb FSR,단불능강저Alb FBR.
Objective To investigate the effects of continuous veno-venous hemofiltration (CVVH) on albumin metabolism of patients with systemic inflammatory response syndrome (SIRS).Methods The clinical data of 28 patients who were admitted to the Nanjing General Hospital of Nanjing Military Command from December 2010 to Decemer 2011 were retrospectively analyzed.All the patients were divided into the control group (8 patients),the low-volume CVVH group (2 000 ml/h,10 patients),and the high-volume CVVH group (4 000 mL/h,10 patients).Two stable isotopes,[1-13C] phenylalanine and d5-phenylalanine,were simultaneously intravenously infused into all the patients.The peak areas were calculated for segments with the mass to charge ratios of 192,194,197,218,219 by the selected ion mode of the gas chromatography mass spectrometry.The fractional synthesis rate (FSR) and the fractional breakdown rate (FBR) of albumin were calculated by the mathematical model.All data were analyzed using the one-way analysis of variance,LSD test or Dunnett's T3 test.Results The FSRs of albumin were 5.8%±0.9%,5.7% ± 1.1% and 5.7% ± 1.0% in the control group,the low-volume CVVH group and the high-volume CVVH group before treatment,with no significant difference between the 3 groups (F =0.04,P>0.05).The FSRs of albumin were 5.9%±0.8%,7.3%±0.9% and 7.8%± 1.1% in the control group,the low-volume CVVH group and the high-volume CVVH group after treatment,with significant difference between the 3 groups (F =9.15,P <0.05).The FSRs of albumin of the low-volume CVVH group and the highvolume CVVH group were significantly higher than that of the control group (t =3.40,3.96,P < 0.05),while no significant difference was detected between the low-volume CVVH group and the high-volume CVVH group in the FSR of albumin (t =1.02,P > 0.05).The FBRs of albumin were 7.0% ± 1.2%,6.5% ± 0.9% and 7.2% ±1.2% in the control group,the low-volume CVVH group and the high-volume CVVH group before treatment,with no significant difference between the 3 groups (F =0.88,P > 0.05).The FBRs of albumin were 6.9% ± 1.1%,6.2%±0.9% and 7.4%± 1.0% in the control group,the low-volume CVVH group and the high-volume CVVH group after treatment.There was no significant difference in the FBR of albumin after treatment between the 3 groups (F =2.82,P > 0.05).Conclusions Simultaneous infusion of multiple isotopes for the detection of FSR and FBR of albumin is effective and feasible to detect the albumin metabolism.CVVH regulates the albumin metabolism in SIRS patients,and it can increase FSR of albumin in SIRS patients,while the FBR of albumin cannot be decreased by CVVH.